Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting

Similar documents
Making the Most of Your Cancer Registry

Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station

2007 Multiple Primary and Histology Coding Rules

Quit Rates of New York State Smokers

An Updated Approach to Colon Cancer Screening and Prevention

Kansas EMS Naloxone (Narcan) Administration

Leveraging Electronic Pathology Reporting in Cervical Cancer Epidemiology: Determinants of Invasive Diagnoses in Kentucky

From Analytics to Action

Stage Data Capture in Ontario

McLean ebasis plus TM

FGSZ Zrt. from 28 February 2019 till 29 February 2020 AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS

Poster Session HRT1317 Innovation Awards November 2013 Brisbane

FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)?

Using Cancer Registration and MDT Data to Provide Information on Recurrent and Metastatic Breast Cancer

Leveraging Your Cancer Registry: A Strategy for Survey Success

Consultant-led Referral to Treatment (RTT) waiting times collection timetable: outcome of consultation

Sleep Market Panel. Results for June 2015

The CIDRZ Experience: use of data to understand patient outcomes and guide program implementation 07 January 2010

Winter Holiday Suicide Myth Continues to be Reinforced in Press Annenberg Public Policy Center Study Finds

South Plains Emergency Medical Services, Inc. P.O. Box Lubbock, Texas 79453

Progress in maternal and child health: Uzbekistan and WHO European Region

Breast Test Wales Screening Division Public Health Wales

Global Fund Approach to Health System Strengthening

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE

18 Week 92% Open Pathway Recovery Plan and Backlog Clearance

Clostridium difficile (C. difficile) and Staphylococcus aureus bacteraemia (MRSA and MSSA) Bi-annual Report. Surveillance: Report:

Cincinnati Children s Hospital Medical Center PHO/OVPCA Constipation Initiative Monthly Report February 2018

The Infection Control Doctor and Clostridium difficile infection. Dr David R Jenkins University Hospitals of Leicester NHS Trust, England

Date : September Permit/License or Registration Application. Permit/License/ Notification/ Registration Description. Remark

Cancer Immunotherapy Pilot Program/ Patents 4 Patients. USPTO BCP Customer Partnership Meeting Alexandria, VA August 2, 2017

STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.

Analysis of Meter Reading Validation Tolerances proposed by Project Nexus

Tri-County Opioid Safety Coalition Data Brief December 2017 Clackamas, Multnomah, and Washington Counties

Avian influenza in poultry, wild and captive birds (AI)

Empowering Weight Loss Charts & Logs Healthy Weight Chart Cholesterol Chart Blood Pressure Chart Exercise Calorie Burning Chart

One Palliative Care Annual Report

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

BJA Performance Measures

Symptom Control During Chemotherapy (SCDC) MN Community Measurement

Curators of the University of Missouri - Combined January 01, 2013 through December 31, 2013 Cost Management Report

Emergency Department Boarding of Psychiatric Patients in Oregon

To view past issues, go to: The New 13-Valent Pneumococcal Conjugate Vaccine (PCV13)

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Data Visualization - Basics

Durham Region Influenza Bulletin: 2017/18 Influenza Season

Bringing the Fight to Cancer Annual Report

Jay H. Hoofnagle, M.D. Director, Liver Disease Research Branch Division of Digestive Diseases and Nutrition National Institute of Diabetes and

Overview of Study Experience (CEOs, only)

GREENWOOD PUBLIC SCHOOL DISTRICT PHYSICAL EDUCATION

Oncology Report to the Community. Northwestern Medicine Central DuPage Hospital and Northwestern Medicine Delnor Hospital

Supplementary Online Content

USING TEAM AUDITS TO IMPROVE IMAGE QUALITY: Our Institution s Experience

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

Curators of the University of Missouri - Combined January 1, 2016 through December 31, 2016

Organ Donation Breakthrough Collaborative Institute of Medicine

Dementia Content Report January Produced By The NHS Choices Reporting Team

Bringing the Fight to Cancer Annual Report

IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE. A Clinical Quality Improvement Program

Education around PML risk and monitoring at NHNN Queen Square MS Centre

EDINBURGH HEALTHCARE NHS TRUST. 4 Edinburgh Healthcare NHS Trust Printed Material,

National Xpert MTB/RIF Programme

ACUTE LYMPHOBLASTIC LEUKEMIA

The State of Measles and Rubella in the WHO European Region

Figure 1: Quantity Dispensed/100 Members (Ambien and Sonata on left axis)

Improvement Initiative for Patient Falls Susan Moffatt-Bruce, B.Sc. (Hon), M.D., Ph.D., FRCS(C), FACS, MBOE, Chief Quality and Patient Safety Officer

Commission on Cancer Updates

th Medical Group Report Card

RADIATION SAFETY Metrics & Reports 2015

Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers

Texas Vendor Drug Program Specialty Drug List Process. February 2019

Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes

Region of Waterloo Public Health and Emergency Services Infectious Diseases, Dental, and Sexual Health

What Computer Tools to Use for Your Quality and Safety Program

East London Community Kidney Service

Successful Falls Prevention in Aged Persons Mental Health. Reducing the risk and decreasing severity of outcome

Spring Understanding the potential of generic substitution

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.

Seasonality of influenza activity in Hong Kong and its association with meteorological variations

ESPA Directorate KPI Report: Quarter 1,

National Cancer Peer Review Programme

Gary M. Levin, BA, CTR FCDS Annual Conference 7/26/2017

FFT and Patient Insight for Improvement. Marie Allen Head of Service User and Carer Experience

North Dakota Board of Pharmacy

Effects of a Televised Two-City Safer Sex Mass Media Campaign Targeting High Sensation-Seeking and Impulsive Decision- Making Young Adults

Jan Feb Mar Apr May Jun Jul Aug Sep X X X X X X X. Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov X X X X X X X X X X X X X

Alignment Strategies at the JPS Health Network

PEDIATRIC SUMMARY REPORT, 2014 EMS & TRAUMA REGISTRIES. Texas Department of State Health Services Injury Epidemiology & Surveillance Branch

MHSC Program Evaluation Mental Health Service Corps. Dana Collins, Social Work Intern Jessica Neufeld, MPH Virna Little, PsyD, LCSW-r, MBA, CCM, SAP

M&E of DSD with Electronic Medical Records

Hand, Foot, and Mouth Disease Situation Update. Hand, Foot, and Mouth Disease surveillance summary

Monitoring of Voriconazole levels at University Hospital. Jason Bowling, MD Rachel Rivera, MD

Pre-hospital thrombolysis (PHT) Clinical Audit Report 30 th November 2007

Measure Up/Pressure Down Medical Group Success

Global Screening of Hearing in Newborns. Update from Portugal

Outbreak Response/Epidemiology Influenza Weekly Report Arkansas

THE PORTUGUESE COMMUNITY SCREENING NETWORK

Recording and measuring the outcome of an ART cycle

The Society for Vascular Surgery Patient Safety Organization: Use of A Quality Registry for Practice Improvement

Transcription:

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting Eric B. Durbin, DrPH, MS, Director of Cancer Informatics Frances E. Ross, CTR, Director of Registry Operations Kentucky Cancer Registry June 21, 2017 North American Association of Central Cancer Registries Annual Conference Albuquerque, NM 1

Overview Treatment and case reporting requirements Possible ways in which reporting requirements may lead to incomplete treatment in central registries SEER rapid response study to examine this question Treatment administration and reporting patterns in Kentucky Recommend best practices for central registry operations to ensure complete treatment capture from hospital facilities

Importance of Complete Treatment Information to Central Cancer Registries Complete treatment information essential to value of central cancer registries Necessary to assess population-based patterns of care Only data source to measure the dissemination of best treatment practices in the community/population Population-based treatment information in combination with molecular markers important to advances in precision medicine Capturing complete treatment information remains a huge challenge for central registries

Central and Hospital Registry Reporting Requirements SEER requires at least 95% complete case reporting for 12-month data submissions NPCR requires at least 90% complete case reporting for 12-month data submissions Commission on Cancer (CoC) hospitals must abstract and transmit cases to state registries within 6 months of diagnosis Kentucky Cancer Registry (KCR) requires reporting within 6 months of diagnosis or within 6 months of date first seen (if not treating facility)

Could Reporting Rules Impair Complete Treatment Capture? Is it possible that 6-month reporting requirements and reporting practices could result in incomplete treatment capture at central cancer registries? What if first course treatment extends beyond 6 months? What if hospital registries fail to re-transmit updated treatment information that is abstracted following the 6-month report? What if central registries do not consolidate new treatment information received after an initial hospital report?

Study Purpose SEER Rapid Response Study sponsored in 2015 Measure and evaluate delays in cancer treatment - Administration of treatment - Capture and reporting of treatment to the Kentucky Cancer Registry (KCR) Specific Aims - Quantify changes in treatment data from time first reported through at least 15 months post diagnosis - Evaluate whether central registry practices should continue to consolidate treatment following first reports

Methods Examined treatment information for invasive adult cancer cases diagnosed in 2014 and reported to the KCR Utilized monthly archival copies of the KCR central registry database to perform the analyses Analyzed data for CoC and non-coc facilities for lung, breast, prostate, colorectal and all sites combined 10% random sample case audit was performed to validate processing of treatment information from archival data sources

KCR s Cancer Patient Data Management System () State mandate requires all non-federal hospitals utilize KCR s Cancer Patient Data Management System () for abstracting and reporting is a web-based hospital cancer registry data management application developed and maintain by KCR automatically reports initial treatment information with case meets COC or non-coc completeness requirements Any subsequent treatment information abstracted by Kentucky hospitals is automatically reported and consolidated into the Kentucky central registry Archived monthly copies of the central registry reflect status of treatment for all patients over time

Archival Databases Examined (15-26 months of follow-up) Month Jan-14 Archives < 15 Jan-14 Mar-15 Apr-15 26 Feb-14 May-15 25 Mar-14 Jun-15 24 Apr-14 Jul-15 23 May-14 Aug-15 22 Jun-14 Sept-15 21 Jul-14 Oct-15 20 Aug-14 Nov-15 19 Sep-14 Dec-15 18 Oct-14 Jan-16 17 Nov-14 Feb-16 16 Dec-14 Dec-14 Feb-16 Mar-16 15 Total Follow-up

Study Data Capture For each eligible case in study - Examined first course treatment information consolidated in central registry across each archival copy of the central registry database Measures - Calculated months from diagnosis to date of treatment being administered - Calculated months from diagnosis to treatment being reported (treatment report existing in central registry) - By modality (surgery, chemo, radiation, hormone, immunotherapy, other, all modalities combined) - By facility type (CoC, non-coc, all combined) Summarized by 95% and 100% case complete treatment and treatment reporting Sites presented include lung, breast, prostate, colorectal, and all sites combined

Results for Lung Cancer Treatment in Kentucky 2014 Lung Cancer Treatment Modality Facility type Month When 95% Cases Treatment Administered Month When 100% Cases Treatment Administered Month When 95% Cases Treatment Reported Month When 100% Cases Treatment Reported Surgery All 4 18 14 26 939 COC 4 18 10 26 868 non-coc 3 8 19 25 71 N Chemo All 4 19 16 26 2034 COC 4 19 14 26 1850 non-coc 3 9 20 26 184 Radiation All 6 16 16 26 1900 COC 6 16 15 26 1748 non-coc 6 8 20 24 152 Hormone All 3 3 12 12 8 COC 3 3 12 12 8 non-coc Immunotherapy All 3 16 17 21 88 COC 3 16 17 20 82 non-coc 3 3 21 21 6 Other All 2 2 19 19 9 COC 2 2 19 19 8 non-coc 0 0 13 13 1

Lung Cancer Treatment and Reporting (All Treatment Modalities)

2014 Breast Cancer Treatment and Reporting (All Treatment Modalities)

2014 Breast Cancer Treatment and Reporting (By Modality)

2014 Prostate Cancer Treatment and Reporting (All Treatment Modalities)

2014 Colorectal Cancer Treatment and Reporting

2014 All Sites Cancer Treatment and Reporting

Summary: Treatment and Reporting Delays

If Additional Treatment Information Not Consolidated into Central Registry Following First Report from Facilities

Conclusions First course treatment administration continues well beyond the 6-month standard for hospital reporting of cases to central registries - 95% of know treatment administered between 5 and 10 months - 5% of treatment is administered through 19 months! Treatment reporting to central registries extends well beyond the 12-month submission standard - 95% treatment reported within 17 months - 5% of treatment reported through 26 months If hospital registries do not re-transmit or central registries do not consolidate additional treatment information following the first facility abstract, nearly 12% of cases will have some missing treatment information In order to maintain complete treatment information, central registry best practices require continuous reporting and consolidation of treatment from hospital registries

Acknowledgements Frances Ross, CTR Tonya Brandenburg, CTR Isaac Hands, MPH Jenny Gregory, MS Jason Jacob, MS NCI/SEER Rapid Response Study Funding HHSN261201300013

Thank you! Eric B. Durbin, DrPH, MS Director of Cancer Informatics Kentucky Cancer Registry ericd@kcr.uky.edu (859) 218-3182